{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T11:23:06Z","timestamp":1791890586091,"version":"4.3.4"},"reference-count":76,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>The drug-coated balloon (DCB) is an emerging percutaneous coronary intervention (PCI) device with theoretical advantages and promising results. Recent clinical observations have demonstrated that DCB tends to have both good efficacy and a good safety profile in the treatment of in-stent restenosis (ISR) for both bare-metal and drug-eluting stents (DES), <jats:italic>de novo<\/jats:italic> coronary artery disease (CAD), and other situation, such as high bleeding risk, chronic total occlusion, and acute coronary syndrome (ACS). Dual antiplatelet therapy (DAPT) has become an essential medication in daily clinical practice, but the optimal duration of DAPT after the implantation of a DCB remains unknown. At the time of the first <jats:italic>in vivo<\/jats:italic> implantation of paclitaxel-DCB for the treatment of ISR in 2006, the protocol-defined DAPT duration was only 1 month. Subsequently, DAPT duration ranging from 1 to 12 months has been recommended by various trials. However, there have been no randomized controlled trials (RCTs) on the optimal duration of DAPT after DCB angioplasty. Current clinical guidelines normally recommend the duration of DAPT after DCB-only angioplasty based on data from RCTs on the optimal duration of DAPT after stenting. In this review, we summarized current clinical trials on DCB-only angioplasty for different types of CADs and their stipulated durations of DAPT, and compared their clinical results such as restenosis, target lesion revascularization (TLR) and stent thrombosis event. We hope this review can assist clinicians in making reasonable decisions about the duration of DAPT after DCB implantation.<\/jats:p>","DOI":"10.3389\/fcvm.2021.762391","type":"journal-article","created":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T22:33:40Z","timestamp":1638398020000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["Duration of Dual Antiplatelet Therapy After Implantation of Drug-Coated Balloon"],"prefix":"10.3389","volume":"8","author":[{"given":"Yuxuan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qichao","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,12,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1161\/01.CIR.0000138929.71660.E0","article-title":"Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis","volume":"110","author":"Scheller","year":"2004","journal-title":"Circulation."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1056\/NEJMoa061254","article-title":"Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter","volume":"355","author":"Scheller","year":"2006","journal-title":"N Engl J Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1056\/NEJMoa0706356","article-title":"Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg","volume":"358","author":"Tepe","year":"2008","journal-title":"N Engl J Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1080\/17425247.2020.1714590","article-title":"Drug-coated balloons in cardiovascular disease: benefits, challenges, and clinical applications","volume":"17","author":"Nestelberger","year":"2020","journal-title":"Expert Opin Drug Deliv."},{"key":"B5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/eurheartj\/ehy855","article-title":"2018 ESC\/EACTS Guidelines on myocardial revascularization","volume":"40","author":"Neumann","year":"2019","journal-title":"Eur Heart J."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1016\/j.jcin.2020.02.043","article-title":"Drug-coated balloons for coronary artery disease: third report of the international DCB consensus group","volume":"13","author":"Jeger","year":"2020","journal-title":"JACC Cardiovasc Interv."},{"key":"B7","doi-asserted-by":"publisher","first-page":"136","DOI":"10.5603\/CJ.a2019.0093","article-title":"Drug-coated balloon treatment in coronary artery disease: recommendations from an asia-pacific consensus group","volume":"28","author":"Her","year":"2021","journal-title":"Cardiol J."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e123","DOI":"10.1161\/CIR.0000000000000404","article-title":"2016 ACC\/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF\/AHA\/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF\/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC\/AHA\/ACP\/AATS\/PCNA\/SCAI\/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF\/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA\/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes, and 2014 ACC\/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery","volume":"134","author":"Levine","year":"2016","journal-title":"Circulation."},{"key":"B9","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/S0140-6736(19)31126-2","article-title":"Drug-coated balloon for treatment of de-novo coronary artery lesions in patients with high bleeding risk (DEBUT): a single-blind, randomised, non-inferiority trial","volume":"394","author":"Rissanen","year":"2019","journal-title":"Lancet."},{"key":"B10","doi-asserted-by":"publisher","first-page":"K125","DOI":"10.4244\/EIJV7SKA21","article-title":"How to use the drug-eluting balloon: recommendations by the German consensus group","volume":"7","author":"Kleber","year":"2011","journal-title":"EuroIntervention."},{"key":"B11","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s00392-013-0609-7","article-title":"Drug-coated balloons for treatment of coronary artery disease: updated recommendations from a consensus group","volume":"102","author":"Kleber","year":"2013","journal-title":"Clin Res Cardiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/ccd.25149","article-title":"Drug-coated balloon treatment of coronary artery disease: a position paper of the Italian Society of Interventional Cardiology","volume":"83","author":"Cortese","year":"2014","journal-title":"Catheter Cardiovasc Interv."},{"key":"B13","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/eurheartj\/ehx419","article-title":"2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"39","author":"Valgimigli","year":"2018","journal-title":"Eur Heart J."},{"key":"B14","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1161\/ATVBAHA.107.150474","article-title":"Cell adhesion mechanisms in platelets","volume":"28","author":"Varga-Szabo","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1253\/circj.CJ-09-0982","article-title":"Basic principles of platelet biology and clinical implications","volume":"74","author":"Angiolillo","year":"2010","journal-title":"Circ J."},{"key":"B16","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/eurheartj\/ehp504","article-title":"Platelet thrombin receptor antagonism and atherothrombosis","volume":"31","author":"Angiolillo","year":"2010","journal-title":"Eur Heart J."},{"key":"B17","doi-asserted-by":"publisher","first-page":"431","DOI":"10.5551\/jat.7633","article-title":"Role of platelets and antiplatelet therapy in cardiovascular disease","volume":"18","author":"Ueno","year":"2011","journal-title":"J Atheroscler Thromb."},{"key":"B18","doi-asserted-by":"publisher","first-page":"3320","DOI":"10.1093\/eurheartj\/ehv511","article-title":"Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Gruntzig lecture ESC 2014","volume":"36","author":"Byrne","year":"2015","journal-title":"Eur Heart J."},{"key":"B19","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1161\/CIRCULATIONAHA.118.038065","article-title":"Ten-year clinical outcomes from a trial of three limus-eluting stents with different polymer coatings in patients with coronary artery disease: results from the ISAR-TEST 4 randomized trial","volume":"139","author":"Kufner","year":"2019","journal-title":"Circulation."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1016\/j.jacc.2014.02.545","article-title":"Current treatment of in-stent restenosis","volume":"63","author":"Alfonso","year":"2014","journal-title":"J Am Coll Cardiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1016\/j.jacc.2020.04.006","article-title":"Drug-coated balloon angioplasty versus drug-eluting stent implantation in patients with coronary stent restenosis","volume":"75","author":"Giacoppo","year":"2020","journal-title":"J Am Coll Cardiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.jcin.2012.01.008","article-title":"Long-term follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter","volume":"5","author":"Scheller","year":"2012","journal-title":"JACC Cardiovasc Interv."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.1161\/CIRCULATIONAHA.108.839282","article-title":"Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis","volume":"119","author":"Unverdorben","year":"2009","journal-title":"Circulation."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1016\/j.jacc.2013.12.006","article-title":"A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: the RIBS V clinical trial (restenosis intra-stent of bare metal stents: paclitaxel-eluting balloon vs everolimus-eluting stent)","volume":"63","author":"Alfonso","year":"2014","journal-title":"J Am Coll Cardiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/ccd.26216","article-title":"A novel drug-coated scoring balloon for the treatment of coronary in-stent restenosis: results from the multi-center randomized controlled PATENT-C first in human trial","volume":"88","author":"Scheller","year":"2016","journal-title":"Catheter Cardiovasc Interv."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e003316","DOI":"10.1161\/CIRCINTERVENTIONS.115.003316","article-title":"Comparison of the efficacy of paclitaxel-eluting balloon catheters and everolimus-eluting stents in the treatment of coronary in-stent restenosis: the treatment of in-stent restenosis study","volume":"9","author":"Pleva","year":"2016","journal-title":"Circ Cardiovasc Interv."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/j.jacc.2012.01.015","article-title":"A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study","volume":"59","author":"Rittger","year":"2012","journal-title":"J Am Coll Cardiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0140-6736(12)61964-3","article-title":"Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial","volume":"381","author":"Byrne","year":"2013","journal-title":"Lancet."},{"key":"B29","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jcin.2013.08.011","article-title":"A prospective, multicenter, randomized trial of paclitaxel-coated balloon versus paclitaxel-eluting stent for the treatment of drug-eluting stent in-stent restenosis: results from the PEPCAD China ISR trial","volume":"7","author":"Xu","year":"2014","journal-title":"JACC Cardiovasc Interv."},{"key":"B30","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jacc.2015.04.063","article-title":"A prospective randomized trial of drug-eluting balloons versus everolimus-eluting stents in patients with in-stent restenosis of drug-eluting stents: the RIBS IV randomized clinical trial","volume":"66","author":"Alfonso","year":"2015","journal-title":"J Am Coll Cardiol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.jcin,0.2017.04.024","article-title":"Neointimal modification with scoring balloon and efficacy of drug-coated balloon therapy in patients with restenosis in drug-eluting coronary stents: a randomized controlled trial","volume":"10","author":"Kufner","year":"2017","journal-title":"JACC Cardiovasc Interv."},{"key":"B32","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ahj.2017.11.008","article-title":"Comparison of drug-eluting stents and drug-coated balloon for the treatment of drug-eluting coronary stent restenosis: a randomized RESTORE trial","volume":"197","author":"Wong","year":"2018","journal-title":"Am Heart J."},{"key":"B33","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.jcin.2017.10.024","article-title":"A randomized comparison of paclitaxel-eluting balloon versus everolimus-eluting stent for the treatment of any in-stent restenosis: the DARE trial","volume":"11","author":"Baan J","year":"2018","journal-title":"JACC Cardiovasc Interv."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.4244\/EIJ-D-17-01079","article-title":"Angiographic and clinical performance of a paclitaxel-coated balloon compared to a second-generation sirolimus-eluting stent in patients with in-stent restenosis: the BIOLUX randomised controlled trial","volume":"14","author":"Jensen","year":"2018","journal-title":"EuroIntervention."},{"key":"B35","doi-asserted-by":"publisher","first-page":"926","DOI":"10.4244\/EIJY14M08_12","article-title":"Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis: the three-year results of the PEPCAD II ISR study","volume":"11","author":"Unverdorben","year":"2015","journal-title":"EuroIntervention."},{"key":"B36","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.jcin.2018.02.037","article-title":"3-year clinical follow-up of the ribs IV clinical trial: a prospective randomized study of drug-eluting balloons versus everolimus-eluting stents in patients with in-stent restenosis in coronary arteries previously treated with drug-eluting stents","volume":"11","author":"Alfonso","year":"2018","journal-title":"JACC Cardiovasc Interv."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1016\/j.jcin.2015.07.023","article-title":"Long-term outcomes after treatment with a paclitaxel-coated balloon versus balloon angioplasty: insights from the pepcad-des study (treatment of drug-eluting stent [DES] in-stent restenosis with sequent please paclitaxel-coated percutaneous transluminal coronary angioplasty [PTCA] catheter)","volume":"8","author":"Rittger","year":"2015","journal-title":"JACC Cardiovasc Interv."},{"key":"B38","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1002\/ccd.26401","article-title":"Two-year results and subgroup analyses of the PEPCAD China in-stent restenosis trial: a prospective, multicenter, randomized trial for the treatment of drug-eluting stent in-stent restenosis","volume":"87","author":"Xu","year":"2016","journal-title":"Catheter Cardiovasc Interv."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1016\/S0735-1097(98)00444-6","article-title":"Angiographic and clinical outcome following coronary stenting of small vessels: a comparison with coronary stenting of large vessels","volume":"32","author":"Akiyama","year":"1998","journal-title":"J Am Coll Cardiol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.carrev.2009.04.007","article-title":"Percutaneous coronary intervention for small vessel coronary artery disease","volume":"11","author":"Biondi-Zoccai","year":"2010","journal-title":"Cardiovasc Revasc Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.jacc.2019.12.046","article-title":"Drug-coated balloon for de novo coronary artery disease: JACC state-of-the-art review","volume":"75","author":"Yerasi","year":"2020","journal-title":"J Am Coll Cardiol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1136\/hrt.2010.195057","article-title":"Paclitaxel-coated balloon versus drug-eluting stent during PCI of small coronary vessels, a prospective randomised clinical trial. The PICCOLETO study. Heart","volume":"96","author":"Cortese","year":"2010"},{"key":"B43","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1016\/j.jacc.2012.09.020","article-title":"A randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels: the BELLO (balloon elution and late loss optimization) study","volume":"60","author":"Latib","year":"2012","journal-title":"J Am Coll Cardiol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1007\/s00392-017-1126-x","article-title":"A multicenter randomized comparison of paclitaxel-coated balloon with plain balloon angioplasty in patients with small vessel disease","volume":"106","author":"Funatsu","year":"2017","journal-title":"Clin Res Cardiol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0140-6736(18)31719-7","article-title":"Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial","volume":"392","author":"Jeger","year":"2018","journal-title":"Lancet"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1007\/s00392-020-01603-2","article-title":"Drug-coated balloon versus drug-eluting stent in small coronary artery lesions: angiographic analysis from the BASKET-SMALL 2 trial","volume":"109","author":"Fahrni","year":"2020","journal-title":"Clin Res Cardiol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1016\/j.jcin.2018.09.009","article-title":"Drug-coated balloon versus drug-eluting stent for small-vessel disease: the RESTORE SVD China randomized trial","volume":"11","author":"Tang","year":"2018","journal-title":"JACC Cardiovasc Interv."},{"key":"B48","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.1016\/j.jcin.2020.08.035","article-title":"Drug-coated balloon versus drug-eluting stent for small coronary vessel disease: PICCOLETO II randomized clinical trial","volume":"13","author":"Cortese","year":"2020","journal-title":"JACC Cardiovasc Interv."},{"key":"B49","doi-asserted-by":"publisher","first-page":"K53","DOI":"10.4244\/EIJV7SKA9","article-title":"The PICCOLETO study and beyond","volume":"7","author":"Cortese","year":"2011","journal-title":"EuroIntervention."},{"key":"B50","doi-asserted-by":"publisher","first-page":"e016224","DOI":"10.1161\/JAHA.120.016224","article-title":"Clinical and angiographic outcomes with drug-coated balloons for de novo coronary lesions: a meta-analysis of randomized clinical trials","volume":"9","author":"Elgendy","year":"2020","journal-title":"J Am Heart Assoc."},{"key":"B51","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/ccd.28705","article-title":"Two-year follow-up of a randomized multicenter study comparing a drug-coated balloon with a drug-eluting stent in native small coronary vessels: the RESTORE small vessel disease China trial","volume":"95","author":"Tian","year":"2020","journal-title":"Catheter Cardiovasc Interv."},{"key":"B52","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s00392-018-1346-8","article-title":"Treatment of large de novo coronary lesions with paclitaxel-coated balloon only: results from a Chinese Institute","volume":"108","author":"Yu","year":"2019","journal-title":"Clin Res Cardiol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ijcard.2016.07.156","article-title":"Clinical value of drug-coated balloon angioplasty for de novo lesions in patients with coronary artery disease","volume":"222","author":"Nishiyama","year":"2016","journal-title":"Int J Cardiol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.amjms.2017.07.005","article-title":"Drug-coated balloon versus drug-eluting stent in primary percutaneous coronary intervention: a feasibility study","volume":"354","author":"Gobic","year":"2017","journal-title":"Am J Med Sci."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1016\/j.jcin.2019.04.016","article-title":"Paclitaxel-coated balloon angioplasty versus drug-eluting stent in acute myocardial infarction: the REVELATION randomized trial","volume":"12","author":"Vos","year":"2019","journal-title":"JACC Cardiovasc Interv."},{"key":"B56","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1016\/j.jcin.2015.08.029","article-title":"Effect of drug-coated balloons in native coronary artery disease left with a dissection","volume":"8","author":"Cortese","year":"2015","journal-title":"JACC Cardiovasc Interv."},{"key":"B57","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/ccd.26257","article-title":"Fractional flow reserve-guided paclitaxel-coated balloon treatment for de novo coronary lesions","volume":"88","author":"Shin","year":"2016","journal-title":"Catheter Cardiovasc Interv."},{"key":"B58","doi-asserted-by":"publisher","first-page":"e0147057","DOI":"10.1371\/journal.pone.0147057","article-title":"Anatomical and physiological changes after paclitaxel-coated balloon for atherosclerotic de novo coronary lesions: serial IVUS-VH and FFR study","volume":"11","author":"Ann","year":"2016","journal-title":"PLoS ONE."},{"key":"B59","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jjcc.2018.07.008","article-title":"Short-term outcomes from drug-coated balloon for coronary de novo lesions in large vessels","volume":"73","author":"Lu","year":"2019","journal-title":"J Cardiol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"6548696","DOI":"10.1155\/2019\/6548696","article-title":"Drug coated balloon-only strategy in de novo lesions of large coronary vessels","volume":"2019","author":"Rosenberg","year":"2019","journal-title":"J Interv Cardiol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/ccd.27724","article-title":"Prospective, large-scale multicenter trial for the use of drug-coated balloons in coronary lesions: the DCB-only all-comers registry","volume":"93","author":"Rosenberg","year":"2019","journal-title":"Catheter Cardiovasc Interv."},{"key":"B62","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ijcard.2015.04.278","article-title":"Drug-coated balloon without stent implantation for chronic total occlusion of coronary arteries: description of a new strategy with an optical coherence tomography assistance","volume":"191","author":"Cortese","year":"2015","journal-title":"Int J Cardiol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.ijcard.2016.09.105","article-title":"Treatment of chronic total occlusions in native coronary arteries by drug-coated balloons without stenting - a feasibility and safety study","volume":"225","author":"Koln","year":"2016","journal-title":"Int J Cardiol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/ccd.27950","article-title":"Percutaneous coronary intervention with drug-coated balloon-only strategy in stable coronary artery disease and in acute coronary syndromes: an all-comers registry study","volume":"93","author":"Uskela","year":"2019","journal-title":"Catheter Cardiovasc Interv."},{"key":"B65","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1093\/eurheartj\/ehi810","article-title":"Primary coronary angioplasty vs. thrombolysis, does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients","volume":"27","author":"Boersma","year":"2006","journal-title":"Eur Heart J."},{"key":"B66","doi-asserted-by":"publisher","first-page":"584","DOI":"10.4244\/EIJV10I5A101","article-title":"Safety and feasibility of a PAclitaxel-eluting balloon angioplasty in primary percutaneous coronary intervention in Amsterdam (PAPPA): one-year clinical outcome of a pilot study","volume":"10","author":"Vos","year":"2014","journal-title":"EuroIntervention."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.4244\/EIJ-D-19-00723","article-title":"Bare metal or drug-eluting stent versus drug-coated balloon in non-ST-elevation myocardial infarction: the randomised PEPCAD NSTEMI trial","volume":"15","author":"Scheller","year":"2020","journal-title":"EuroIntervention."},{"key":"B68","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/joic.12495","article-title":"Real-life experience of a stent-less revascularization strategy using a combination of excimer laser and drug-coated balloon for patients with acute coronary syndrome","volume":"31","author":"Harima","year":"2018","journal-title":"J Interv Cardiol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"l2222","DOI":"10.1136\/bmj.l2222","article-title":"Duration of dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting stent: systematic review and network meta-analysis","volume":"365","author":"Yin","year":"2019","journal-title":"BMJ."},{"key":"B70","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur Heart J."},{"key":"B71","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/FJC.0000000000000856","article-title":"Low-dose ticagrelor in patients with high ischemic risk and previous myocardial infarction: a multicenter prospective real-world observational study","volume":"76","author":"Cesaro","year":"2020","journal-title":"J Cardiovasc Pharmacol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ijcard.2021.10.138","article-title":"Prevalence and clinical implications of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes: insights from the START-ANTIPLATELET registry","volume":"345","author":"Cesaro","year":"2021","journal-title":"Int J Cardiol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1016\/j.jcin.2017.06.021","article-title":"The SABRE trial (sirolimus angioplasty balloon for coronary in-stent restenosis): angiographic results and 1-year clinical outcomes","volume":"10","author":"Verheye","year":"2017","journal-title":"JACC Cardiovasc Interv."},{"key":"B74","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jcin.2018.11.040","article-title":"Treatment of coronary drug-eluting stent restenosis by a sirolimus- or paclitaxel-coated balloon","volume":"12","author":"Ali","year":"2019","journal-title":"JACC Cardiovasc Interv."},{"key":"B75","doi-asserted-by":"publisher","first-page":"E496","DOI":"10.1002\/ccd.28863","article-title":"Long-term follow-up after sirolimus-coated balloon use for coronary artery disease. Final results of the Nanolute study","volume":"96","author":"El-Mokdad","year":"2020","journal-title":"Catheter Cardiovasc Interv."},{"key":"B76","doi-asserted-by":"publisher","first-page":"94","DOI":"10.2459\/JCM.0000000000001070","article-title":"Clinical performance of a novel sirolimus-coated balloon in coronary artery disease: EASTBOURNE registry","volume":"22","author":"Cortese","year":"2021","journal-title":"J Cardiovasc Med (Hagerstown)."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.762391\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T22:33:43Z","timestamp":1638398023000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.762391\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,1]]},"references-count":76,"alternative-id":["10.3389\/fcvm.2021.762391"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2021.762391","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,1]]},"article-number":"762391"}}